Skip to main content
Erschienen in: Journal of Genetic Counseling 2/2018

10.02.2018 | Original Research

An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data

verfasst von: Stephanie A. Cohen, Courtney Lynam Scherr, Dawn M. Nixon

Erschienen in: Journal of Genetic Counseling | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Women with BRCA mutations, at significantly increased risk for breast and ovarian cancer, do not consistently adhere to management guidelines due to lack of awareness and challenges tracking appointments. We developed an iPhone application (app) to help BRCA carriers manage their surveillance. We explored baseline awareness and adherence to surveillance guidelines and analytic data from 21 months of app use. Descriptive statistics were calculated on responses (N = 86) to a survey about surveillance awareness and practices. The majority were aware of breast surveillance guidelines, but only one third were aware of ovarian surveillance guidelines. In practice, the majority reported a clinical breast exam within 6 months, just over half reported a mammogram and breast MRI in the last year, and under half reported ovarian surveillance in the last year. Nearly 50% reported difficulty remembering appointments. Although only 69 received access codes, 284 unique users attempted to enter the app, which was visible in the iTunes store but only available to those with a study code. Evaluation of analytic data demonstrated user engagement with study participants accessing the app 427 times over the 21-month time period (range 2–57; mean = 6.28). Results indicate participants were more likely to know screening guidelines than practice them. There was interest in the app and users were engaged, suggesting app value. We will send a follow-up survey after 18 months of app use for additional evaluation and feedback.
Literatur
Zurück zum Zitat Ajzen, I., & Fishbein, M. (1980) Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice Hall. Ajzen, I., & Fishbein, M. (1980) Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice Hall.
Zurück zum Zitat Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., …, Lyon, E. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics Part A, 118A(3), 201–209. https://doi.org/10.1002/ajmg.a.10102. Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., …, Lyon, E. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics Part A, 118A(3), 201–209. https://​doi.​org/​10.​1002/​ajmg.​a.​10102.
Zurück zum Zitat Buchanan, A. H., Voils, C. I., Schildkraut, J. M., Fine, C., Horick, N. K., Marcom, P. K., …, Skinner, C. S. (2017). Adherence to recommended risk management among unaffected women with a BRCA mutation. Journal of Genetic Counseling, 26(1), 79–92. Buchanan, A. H., Voils, C. I., Schildkraut, J. M., Fine, C., Horick, N. K., Marcom, P. K., …, Skinner, C. S. (2017). Adherence to recommended risk management among unaffected women with a BRCA mutation. Journal of Genetic Counseling, 26(1), 79–92.
Zurück zum Zitat Calderon-Margalit, R., & Paltiel, O. (2004). Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. International Journal of Cancer, 112(3), 357–364.CrossRefPubMed Calderon-Margalit, R., & Paltiel, O. (2004). Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. International Journal of Cancer, 112(3), 357–364.CrossRefPubMed
Zurück zum Zitat Champion, V. L., & Skinner, C. S. (2003). Differences in perceptions of risk, benefits, and barriers by stage of mammography adoption. Journal of Women's Health, 12(3), 277–286.CrossRefPubMed Champion, V. L., & Skinner, C. S. (2003). Differences in perceptions of risk, benefits, and barriers by stage of mammography adoption. Journal of Women's Health, 12(3), 277–286.CrossRefPubMed
Zurück zum Zitat Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., …, Weitzel, J. N. (2010). Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network, 8(5), 562–594. https://doi.org/10.6004/jnccn.2010.0043. Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., …, Weitzel, J. N. (2010). Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network, 8(5), 562–594. https://​doi.​org/​10.​6004/​jnccn.​2010.​0043.
Zurück zum Zitat Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Friedman, S., Garber, J., …, Whelan, A. (2012). NCCN guidelines version 1.2012 genetic/familial high-risk assessment: breast and ovarian. Retrieved from nccn.org. Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Friedman, S., Garber, J., …, Whelan, A. (2012). NCCN guidelines version 1.2012 genetic/familial high-risk assessment: breast and ovarian. Retrieved from nccn.​org.
Zurück zum Zitat Daly, M. B., Pilarski, R., Axilbund, J., Buys, S. S., Crawford, B., Farmer, M., & et al. (2014). NCCN guidelines version 2.2014 genetic/familial high-risk assessment: breast and ovarian. NCCN Guidelines. Daly, M. B., Pilarski, R., Axilbund, J., Buys, S. S., Crawford, B., Farmer, M., & et al. (2014). NCCN guidelines version 2.2014 genetic/familial high-risk assessment: breast and ovarian. NCCN Guidelines.
Zurück zum Zitat Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., …, Wiesner, G. L. (2017). NCCN guidelines version 2.2017 panel members: genetic/familial high-risk assessment: breast and ovarian (pp. 1540-1405). Retrieved from Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., …, Wiesner, G. L. (2017). NCCN guidelines version 2.2017 panel members: genetic/familial high-risk assessment: breast and ovarian (pp. 1540-1405). Retrieved from
Zurück zum Zitat Davis, F. D. (1989). Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly, 319–340. Davis, F. D. (1989). Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly, 319–340.
Zurück zum Zitat DiMatteo, M. R., Hays, R. D., Gritz, E. R., Bastani, R., Crane, L., Elashoff, R., …, Marcus, A. (1993). Patient adherence to cancer control regimens: scale development and initial validation. Psychological Assessment, 5(1), 102. DiMatteo, M. R., Hays, R. D., Gritz, E. R., Bastani, R., Crane, L., Elashoff, R., …, Marcus, A. (1993). Patient adherence to cancer control regimens: scale development and initial validation. Psychological Assessment, 5(1), 102.
Zurück zum Zitat Free, C., Phillips, G., Watson, L., Galli, L., Felix, L., Edwards, P., …, Haines, A. (2013). The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Medicine, 10(1), e1001363. https://doi.org/10.1371/journal.pmed.1001363. Free, C., Phillips, G., Watson, L., Galli, L., Felix, L., Edwards, P., …, Haines, A. (2013). The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Medicine, 10(1), e1001363. https://​doi.​org/​10.​1371/​journal.​pmed.​1001363.
Zurück zum Zitat Grann, V., Patel, P., Jacobson, J., Warner, E., Heitjan, D., Ashby-Thompson, M., …, Neugut, A. (2011). Comparative effectiveness of screening and prevention strategies among <i>BRCA1/2</i>-affected mutation carriers. Breast Cancer Research and Treatment, 125(3), 837–847. https://doi.org/10.1007/s10549-010-1043-4. Grann, V., Patel, P., Jacobson, J., Warner, E., Heitjan, D., Ashby-Thompson, M., …, Neugut, A. (2011). Comparative effectiveness of screening and prevention strategies among <i>BRCA1/2</i>-affected mutation carriers. Breast Cancer Research and Treatment, 125(3), 837–847. https://​doi.​org/​10.​1007/​s10549-010-1043-4.
Zurück zum Zitat Julian-Reynier, C., Mancini, J., Mouret-Fourme, E., Gauthier-Villars, M., Bonadona, V., Berthet, P., …, Nogues, C. (2011). Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. European Journal of Human Genetics, 19(5), 500–506. Julian-Reynier, C., Mancini, J., Mouret-Fourme, E., Gauthier-Villars, M., Bonadona, V., Berthet, P., …, Nogues, C. (2011). Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. European Journal of Human Genetics, 19(5), 500–506.
Zurück zum Zitat Le-Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez-Barrera, A., Hortobagyi, G. N., …, Arun, B. K. (2011). Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer, 117(17), 3900–3907. https://doi.org/10.1002/cncr.25971. Le-Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez-Barrera, A., Hortobagyi, G. N., …, Arun, B. K. (2011). Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer, 117(17), 3900–3907. https://​doi.​org/​10.​1002/​cncr.​25971.
Zurück zum Zitat Llort, G., Chirivella, I., Morales, R., Serrano, R., Sanchez, A. B., Teulé, A., …, Grana, B. (2015). SEOM clinical guidelines in hereditary breast and ovarian cancer. Clinical & Translational Oncology, 17, 956. Llort, G., Chirivella, I., Morales, R., Serrano, R., Sanchez, A. B., Teulé, A., …, Grana, B. (2015). SEOM clinical guidelines in hereditary breast and ovarian cancer. Clinical & Translational Oncology, 17, 956.
Zurück zum Zitat McKinnon, W., Naud, S., Ashikaga, T., Colletti, R., & Wood, M. (2007). Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. Journal of Genetic Counseling, 16(4), 433–456. https://doi.org/10.1007/s10897-006-9078-8.CrossRefPubMed McKinnon, W., Naud, S., Ashikaga, T., Colletti, R., & Wood, M. (2007). Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. Journal of Genetic Counseling, 16(4), 433–456. https://​doi.​org/​10.​1007/​s10897-006-9078-8.CrossRefPubMed
Zurück zum Zitat O’Neill, S. C., Valdimarsdottir, H. B., Demarco, T. A., Peshkin, B. N., Graves, K. D., Brown, K., …, Schwartz, M. D. (2010). BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-010-0881-4. O’Neill, S. C., Valdimarsdottir, H. B., Demarco, T. A., Peshkin, B. N., Graves, K. D., Brown, K., …, Schwartz, M. D. (2010). BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Research and Treatment. https://​doi.​org/​10.​1007/​s10549-010-0881-4.
Zurück zum Zitat Paluch-Shimon, S., Cardoso, F., Sessa, C., Balmana, J., Cardoso, M., Gilbert, F., & Senkus, E. (2016). Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening. Annals of Oncology, 27(suppl_5), v103–v110.CrossRefPubMed Paluch-Shimon, S., Cardoso, F., Sessa, C., Balmana, J., Cardoso, M., Gilbert, F., & Senkus, E. (2016). Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening. Annals of Oncology, 27(suppl_5), v103–v110.CrossRefPubMed
Zurück zum Zitat Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 11(10), 1115–1118. Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 11(10), 1115–1118.
Zurück zum Zitat Pichert, G., Jacobs, C., Jacobs, I., Menon, U., Manchanda, R., Johnson, M., …, Izatt, L. (2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. Familial Cancer, 9(3), 313–319. https://doi.org/10.1007/s10689-010-9333-x. Pichert, G., Jacobs, C., Jacobs, I., Menon, U., Manchanda, R., Johnson, M., …, Izatt, L. (2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. Familial Cancer, 9(3), 313–319. https://​doi.​org/​10.​1007/​s10689-010-9333-x.
Zurück zum Zitat Rodriguez, M. C., Ooms, A., Montanez, M., & Yan, Y. L. (2005). Perceptions of online learning quality given comfort with technology, motivation to learn technology skills, satisfaction, and online learning experience. Online Submission. Rodriguez, M. C., Ooms, A., Montanez, M., & Yan, Y. L. (2005). Perceptions of online learning quality given comfort with technology, motivation to learn technology skills, satisfaction, and online learning experience. Online Submission.
Zurück zum Zitat Wainberg, S., & Husted, J. (2004). Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiology, Biomarkers & Prevention, 13(12), 1989–1995. Wainberg, S., & Husted, J. (2004). Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiology, Biomarkers & Prevention, 13(12), 1989–1995.
Zurück zum Zitat Walker, J. L., Powell, C. B., Chen, L. M., Carter, J., Bae Jump, V. L., Parker, L. P., …, Gibb, R. K. (2015). Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer, 121(13), 2108–2120. Walker, J. L., Powell, C. B., Chen, L. M., Carter, J., Bae Jump, V. L., Parker, L. P., …, Gibb, R. K. (2015). Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer, 121(13), 2108–2120.
Metadaten
Titel
An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data
verfasst von
Stephanie A. Cohen
Courtney Lynam Scherr
Dawn M. Nixon
Publikationsdatum
10.02.2018
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 2/2018
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0224-x

Weitere Artikel der Ausgabe 2/2018

Journal of Genetic Counseling 2/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.